SMTL ID : 6l8l.1 (3 other biounits)

C-Src in complex with ibrutinib

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.89 Å

Oligo State

monomer

Ligands

1 x 1E8: 1-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one(Non-covalent)

1E8.1: 16 residues within 4Å: Chain A: L.26, G.27, V.34, A.46, K.48, I.89, T.91, E.92, M.94, G.97, S.98, D.101, L.146, A.156, D.157, F.158 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.34, A:V.34, A:K.48, A:K.48, A:L.146, A:D.157 Hydrogen bonds: A:T.91, A:T.91, A:M.94, A:S.98, A:D.101 pi-Stacking: A:F.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Guo, M. et al., Characterization of ibrutinib as a non-covalent inhibitor of SRC-family kinases. Bioorg.Med.Chem.Lett. (2020)

Release Date

2020-11-11

Peptides

Proto-oncogene tyrosine-protein kinase Src: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase Src

Related Entries With Identical Sequence